Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
It's from a press release, but the conference is at the IBS 15th annual tides conference lots of pharma companies there Pfizer, Glaxosmithkline, Biogen Idec, Novartis etc.
http://finance.yahoo.com/news/rxi-pharmaceuticals-present-ibcs-15th-110200237.html
here is some info where it is held at:
This conference is being held May 12-15, 2013 at the Hynes Convention Center, Boston, MA. For more information visit: http://www.ibclifesciences.com/TIDES
don't know though if regular people can get in though
I doubt it , I think it's just a presentation. I say that because of the PR today on earnings for RXII CEO states phase 1 is close to completion. But you never know! We shall see tomorrow morning!
Presentation out today at 4:15 p.m est time. Well presentation slides will be out after it's done on website. Pamela Pavco our CMO will show presentation of RXI-109 reducing dermal scarring.
We need more volume tomorrow, hopefully would be nice to see unblinded phase 1a single dose results for RXI-109 tomorrow! We need some news to move this thing upwards!
Poster Presentation for today May 9th, 2013 is now up on website. POster is on PVR and other ocular disorders. here is the link: http://www.rxipharma.com/wp-content/uploads/2013/05/7-ARVO-Novel-Anti-CTGF-RNAi-Therapy-for-Treatment-of-PVR-and-Other-Disorders_Poster.pdf
The reason why people are confused is because the CEO slipped up and said around April they might have the results. Initially though they said Q2 2013. So I think it is taking longer to get the data collected. remember they have to perform a histology on the patients when they can and collect the data together. The bottom line is we should see it in a few weeks here shortly.
I'm buying more, typical huge drop before 2 conferences next week. We have Monday with poster presentation for Retinoblastoma using SdrxRNA, and then on Thursday another poster presentation on PVR retinal detachment. I'm loading up more, this drop is not warranted
Those presentations at ARVO should help give the stock a slight boost next week. The good part is that both presentations will be available for viewing on the website afterwards.
Yah I saw that press release this morning, this is good. For them to announce a press release about an analyst meeting and starting of phase 2 RXI-109 it leads me to believe the phase 1 data must be phenomenal. Also they said they are unblinding both phase 1 studies in middle of this year, so I say in a month or 2.
3.8 mil shares traded hands? I'm sure positive it wasn't retailers doing the trading today. We were up at 11% at the high point of the day and then tankage at close. Pure Manipulation by Money managers!
I wouldn't say interesting because every pop has gone down. Which leads me to believe big selling is happening. Personally though with phase 1 unblinded data approaching I'm holding long.
I agree, I will watch it today. If it goes lower then I'm gonna buy more shares for my average. With results of phase 1 RXI-109 being unblinded I don't see why anyone would sell now!
With the stock dropping like this I'm ready to add more to my position. No reason for this stock to continue to drop like this! Once unblinded results are RXII will be over .35 +
This is good news for the direction of the company. I can't believe we are able to buy this company for as low as .23 cents per share.
http://finance.yahoo.com/news/rxi-pharmaceuticals-appoints-h-paul-110500927.html
I will post this here for new investors to see how powerful RXI-109 is and the future it holds for RXI pharmaceuticals self delivery RNAI platform. I would like a sticky on this one, otherwise I will do it!
http://www.lifesciadvisors.com/clientinfo/rxi/RXi__LSA_Initiation_Report_11-28-12__clientinfo.pdf
I agree. The reason is because we will see early efficacy. When the result is unblinded and we see that RXI-109 single dose reduces scarring by 30% or more then the stock will fly! I hope we see some results this next week!
if we don't get any results tomorrow then next week is the last week of April. I'm assuming we should here something by then! GL to all! Long and Strong!
Seems like RXI pharma is growing! best time to get inis now before its pipeline gets deeper and better. Now it seems Pamela Pavco has applied to the NIH (national institute of health) to try and receive $252,000 for Retinoblastoma trials ( rare disease- Cancer of the eye). They showed in rats to turn off the gene that causes the cancer.
DEVELOPMENT OF SD-RXRNAS AS THERAPY FOR RETINOBLASTOMA AND OTHER MALIGNANCIES
Awardee Organization: RXI PHARMACEUTICALS CORPORATION
http://projectreporter.nih.gov/project_info_description.cfm?projectnumber=1R43CA165899-01A1
I agree zorden. Now that RXII got OPKO health RNA patents they can then use the patent for cancer, etc. I decided to get into this company because look at the value of biotechs that treat rare diseases, unmet needs and orphan drugs. Biogen Idec, regeneron, Alexion, Biomarin, etc. all treat rare diseases and their stock prices are sky high.
Here is RXII early in the stages, but the ability to treat unmet needs, and orphan drugs with superior technology. In my words of wisdom " Best time to buy a biotech stock is when its low". Can you believe right now you can get RXII for .25 cents? 4 to 5 years from now everyone will wish they would have bought some shares of RXII at this low price.
Well I agree. The problem with RNA interference in the past was not that RNA interference didn't work , the problem was that there was no acceptable delivery method to make the RNAi drug work.
Now with RXI pharma's self delivering technology, they are able to target and treat rare diseases. Heck even dr. frost knows that with the self delivering technology RXI can go after cancer, immune diseases, rare diseases etc. which is why Dr. Frost gave up his RNA patents to RXI. he knows they can get the job done now on those patents!
Exactly on royalties. Also why do you think Dr. Frost gave all of OPKOS health technologies to RXII??? He probably saw the technology first hand and realized that with RXI's self delivery system they could use the 12 patents from opko health. The patents target Cancer, eye disease, cardiovascular, etc.
Agreed seems to be holding a base around this area. I wonder though what you guys will think will happen on good phase 1 results? Will it pop over .30 + cents ?
Old video but talks about Dr. Craig Mello and his partner on receiving the nobel prize for RNA interference.
On HIV im medical journal? Plus its only phase 1 , but I doubt they would send bad results to their peers to be published in a prestigious medical journal.
Good to see the CEO is still confident to buy 90,000 shares on the open market! The HIV phase 1 should boost up the stock once again. But still know that for all of us investors of Inovio the company is still in the early stages of testing. Phase 1 HIV positive results should boost the stock maybe 15% to 20% possibly!
Well stock what I'm saying for example is that lets say currently you hold 40,000 shares. Today you will see a drop, so you get out and then let INO go down today, then buy back in and have more shares like 60,000 shares + . Why not? The key is to use chrontech data as an advantage.
Well I'm off to sleep now but I would say despite chronvac C not being INO's drug people will still view it as a partnership and will punish INO accordingly. I think there will be a sell off tomorrow. The question on how much? I have no idea, but it will sell off tomorrow. I already have sold INO for now because I want to see how much it drops and then possibly buy back in after everything settles!
Yah I have no doubt INO will drop slightly on the Hep C news. I think I see now why chrontech postponed results from Q4 2012 to Q1 2013, maybe they were banking on the immune response being stronger over time?
Anyways I will wait to buy back into INO after the dust has settled a bit. I sold INO for now because I think tomorrow INO will tank hard. You can always buy back in afterwards at a lower price if you want to get in!
But the HIV results won't come out right away like tomorrow. Once INO dips a bit on this chrontech result then you can rebuy back in afterwards. I highly doubt the HIV result will be out a day after the Chronvac C results.
This way you can avoid tomorrows sell off , wait till its clear then buy back in and obtain more shares of INO. Gotta think it smart!
Well I was kind of put off by the mixed results from INO and I may buy it back later if the trials go well. But I'm interested in this biotech stock I have seen the video and done some research I want to start off with 65,000 shares and may add from there.
From what I understand phase 1 results for RX-109 should be out sometime in April correct?
I see the new vaccines from INO use new electroporation like cellectra, and the luekimia one uses elgen-1000. The chronvac C one seemed to use an old electroporation device medpulser, could this have strayed results to be mixed? also the antigen used may not have helped.
These mixed results is not as good as they should have been. I'm thinking to sell and wait for it to dip lower then buy back in again. I have a feeling people will punish INO stock tomorrow anyways. Best to get in after it goes down a bit!
Not gonna lie it takes time to go through trials the good news is the new breakthrough designation rule from FDA that allows certain drugs to pass through is the results in phase 1 are really stellar.so maybe not as long as you think!
But INO was able to allow T-cells to enter the liver to clear the virus. No other company has been able to get T-cells into the liver to clear the hepatitis B virus!
http://www.redorbit.com/news/health/1112729285/inovio-therapeutic-hepatitis-b-vaccine-killer-t-cells-demonstrate-potential/
MonyMony is that new says April 1 at the top but shows March 2012 underneath? Anyways I hope we hear something new from chrontech on this study.
Also I'm a blogger and I would like to publish my article on motley fool but I have to wait till INO is over $200 mil market cap before they will let me post it. I have a good one ready to go when INO goes over that $200 mil market cap which should be soon.
But either way still too low if INO gets bought out for $2.95. Think about if their technology proves to work. They are targeting HIV, Cancer, Hep C, Malaria that should put their valuation somewhere in the billions. Not be sold in the milions!
I would talk about the doubling of flu rate from 20% t 40% efficacy in elderly. Also talk about the positive leukimia interim data and upcoming HIV data in medical journal. Other than that maybe some new trials starting like INO-5150 prostate cancer vaccine starting in 2013 and INO-8000 hep c vaccine (INO's vaccine) starting 2nd half of 2013!
The new authorized shares from 300,000 to 600,000 I'm gonna vote in favor of it.
1. For starters it can allow INO to partner out more of it's candidates or buyout a company that compliments its technology.
2. 2nd more importantly it will block a hostile takeover. Do any of you want to see INO bought out like YMI was for $2.47 a share???? If INO doesn't get the authorized shares it won't have a way to block big pharma from doing a hostile takeover.
I agree CM live. Also INO will improve upon the technology. On INO-8000 hep c vaccine that is INovios vaccine it targets both genotype 1a and 1b but the difference is , it's not gonna use Standard of care with the vaccine like chronvac-c! It will just be the vaccine and the new electroporation device "Cellectra" (same one used for Pennvax B hiv study! INO-8000 is set to start 2nd half of 2013!
Holy smokes someone just bought 1 million shares in 15 minutes. HA!